BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23680223)

  • 1. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.
    Duffy SW; Parmar D
    Breast Cancer Res; 2013 May; 15(3):R41. PubMed ID: 23680223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
    Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
    J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.
    Zahl PH; Jørgensen KJ; Gøtzsche PC
    Br J Cancer; 2013 Oct; 109(7):2014-9. PubMed ID: 23963144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England.
    Blyuss O; Dibden A; Massat NJ; Parmar D; Cuzick J; Duffy SW; Sasieni P
    Cancer Med; 2023 Jan; 12(2):1878-1887. PubMed ID: 35851849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
    Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
    Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands.
    Ripping TM; Verbeek AL; Fracheboud J; de Koning HJ; van Ravesteyn NT; Broeders MJ
    Int J Cancer; 2015 Aug; 137(4):921-9. PubMed ID: 25612892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdiagnosis in organised mammography screening in Denmark. A comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMC Womens Health; 2009 Dec; 9():36. PubMed ID: 20028513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England.
    Duffy SW; Tabar L; Olsen AH; Vitak B; Allgood PC; Chen TH; Yen AM; Smith RA
    J Med Screen; 2010; 17(1):25-30. PubMed ID: 20356942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Richman IB; Long JB; Soulos PR; Wang SY; Gross CP
    Ann Intern Med; 2023 Sep; 176(9):1172-1180. PubMed ID: 37549389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls in accurate estimation of overdiagnosis: implications for screening policy and compliance.
    Feig SA
    Breast Cancer Res; 2013; 15(4):105. PubMed ID: 23927453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reality check for overdiagnosis estimates associated with breast cancer screening.
    Etzioni R; Xia J; Hubbard R; Weiss NS; Gulati R
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25362701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 20. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.